DarioHealth Files Definitive Proxy Statement

TL;DR

DarioHealth proxy filed, annual meeting Dec 18. Vote your shares!

AI Summary

DarioHealth Corp. filed its definitive proxy statement on October 24, 2024, for its annual meeting on December 18, 2024. The company, formerly known as LabStyle Innovations Corp., is seeking shareholder approval for various corporate matters. The filing indicates no fee was required for this submission.

Why It Matters

This filing provides shareholders with crucial information regarding upcoming votes, including director elections and other corporate governance matters, allowing them to make informed decisions.

Risk Assessment

Risk Level: low — This is a routine filing of a proxy statement, which is standard for publicly traded companies and does not inherently introduce new risks.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

• DarioHealth Corp. (company) — Registrant
• LabStyle Innovations Corp. (company) — Former Company Name
• December 18, 2024 (date) — Annual Meeting Date
• October 24, 2024 (date) — Filing Date

FAQ

Key Financial Figures

• $4.05 — mmon Stock), with a conversion price of $4.05 per share (the " Series A-1 Preferred S
• $3.334 — mmon Stock), with a conversion price of $3.334 per share (the " Series B Preferred Sto
• $3.392 — mmon Stock), with a conversion price of $3.392 per share (the " Series B-3 Preferred S
• $2.02 — mmon Stock), with a conversion price of $2.02 per share (the " Series C Preferred Sto
• $2.14 — mmon Stock), with a conversion price of $2.14 per share (the " Series C-2 Preferred S
• $6,500 — he solicitation of proxies for a fee of $6,500 plus customary expenses. No Right of A
• $35 million — ape, he helped lead the company through $35 million in private financing, followed by the c

Filing Documents

• tm2426663d1_def14a.htm (DEF 14A) — 295KB
• 0001104659-24-111163.txt ( ) — 296KB

From the Filing

DEF 14A 1 tm2426663d1_def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the Appropriate Box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.14a-12 DARIOHEALTH CORP. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): x No fee required ¨ Fee paid previously with preliminary materials: ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 DarioHealth Corp. 322 W. 57th St. New York, New York 10019 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held On Wednesday, December 18, 2024 You are cordially invited to attend an annual meeting of the stockholders (the " Meeting ") of DarioHealth Corp. (the " Company "), which will be held at 16:00 (Israel Time) on Wednesday, December 18, 2024, at our Israeli office, located at 5 Tarshish St. Caesarea Industrial Park 3088900, Israel 2 nd Floor. We intend to hold the annual meeting for the following purposes: 1. To re-elect Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Yoav Shaked, Jon Kaplan and Adam K. Stern as directors to serve on the Company's Board of Directors (the " Board ") for a one-year term that expires at the 2025 Annual Meeting of Stockholders, or until their successors are elected and qualified or until their earlier resignation or removal; 2. To ratify the appointment by the Audit Committee of the Board of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; 3. To transact any other business as may properly come before the Meeting or any adjournments thereof. All stockholders are cordially invited to attend the Meeting. If your shares are registered in your name, please bring the admission ticket attached to your proxy card. If your shares are registered in the name of a broker, trust, bank or other nominee, you will need to bring a proxy or a letter from that broker, trust, bank or other nominee or your most recent brokerage account statement, that confirms that you are the beneficial to the meeting. The Board has fixed the close of business on October 24, 2024 as the record date for the Meeting. Only stockholders on the record date are entitled to notice of and to vote at the meeting and at any adjournment or postponement thereof. In addition, shareholders who intend to solicit proxies in support of director nominees other than the company's nominees must also comply with the additional requirements of Rule 14a-19(b). Your vote is important regardless of the number of shares you own. The Company requests that you complete, sign, date and return the enclosed proxy card without delay in the enclosed postage-paid return envelope, even if you now plan to attend the Meeting. You may revoke your proxy at any time prior to its exercise by delivering written notice or another duly executed proxy bearing a later date to the Secretary of the Company, or by attending the Meeting and voting in person. Important Notice Regarding the Availability of Proxy Materials for the Meeting to be held on December 18, 2024 The proxy statement, proxy card and Annual Report are also available at http://www.dariohealth.com/DH2024Proxy.pdf Stockholders may also obtain additional paper or e-mail copies of these materials at no cost by writing to DarioHealth Corp., 322 W. 57th St. New York, New York 10019, and/or via electronic mail to ir@dariohealth.com, Attention: Secretary. Securities and Exchange Commission rules allow us to furnish proxy materials to our stockholders over the internet. You may also have access to the materials for the Meeting by visiting the website: http://mydario.investorroom.com. You may also cast your vote by visiting www.proxyvote.com if you hold your shares in "street name," or www.vstocktransfer.com/proxy if you are a registered stockholder. You may also authorize a proxy to vote your shares over the internet. In order to vote over the internet, you must have your stockholder identification number, which is set forth in the Notice of Internet Availability of Proxy Materials mailed to you. You may also request a paper proxy card to submit your vote by mail. If you have any questions regarding the completion of the enclosed proxy card or would like directions to the Meeting, please call (972)-4770-6377, and/or via electronic mail to ir@

View Full Filing

View this DEF 14A filing on SEC EDGAR